The stock may have dropped a ton, but Leede Jones Gable analyst Douglas W. Loe is advising investors... Read More
Investors should be gearing up for some movement in the biotech space, says iA Capital Markets analy... Read More
The Healthcare space has taken it on the chin this year, as stocks across the board are down by well... Read More
It’s been an uncomfortable stretch for fans of Healthcare stocks, with names across the board losi... Read More
New clinical data from biotechnology company IMV Inc (IMV Stock Quote, Charts, News, Analysts, Finan... Read More
Research Capital Corporation analyst André Uddin remains interested in IMV Inc (IMV Inc Stock Quot... Read More
Research Capital Corporation analyst André Uddin is staying bullish on biotech name IMV (IMV Stock... Read More
2020 has certainly been one for the ages and from an investment point of view the healthcare sector ... Read More
Impressive cancer trial results are keeping Industrial Alliance Securities analyst Chelsea Stellick ... Read More
Echelon Capital Markets analyst Douglas Loe is staying bullish on Canadian clinical-stage biopharmac... Read More
Biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) is a high risk, high reward stock you sh... Read More
Should you be buying IMV (IMV Stock Quote, Chart, News TSX:IMV)? The Halifax-based biopharm company ... Read More
Echelon Wealth Partners analyst Douglas Loe said there’s no change to his investment thesis on cli... Read More
There’s no change in analyst Douglas Loe’s valuation or development timelines for clinical-stage... Read More
New clinical results from biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) signal a less ... Read More
Immuno-oncology company IMV (IMV Stock Quote, Chart TSX:IMV) has announced new data from its lead ca... Read More
Echelon Wealth Partners analyst Doug Loe is holding steady on his estimation of IMV (IMV Stock Quote... Read More
Biotech company IMV (IMV Stock Quote, Chart TSX:IMV) got a target reduction Friday from Mackie Resea... Read More